Our research spans molecular medicine, clinical trials, translational science, and therapeutic development. We are committed to generating impactful discoveries that address fundamental questions in human health and disease.
Principal investigator · Prof. Guido Bocci
Translational pharmacology of antineoplastic drugs, with focus on metronomic chemotherapy, pharmacogenetics, and therapeutic drug monitoring.
Principal investigator · Prof. Di Paolo
Therapeutic drug monitoring, pharmacogenetic analyses, and dose individualization across oncology, hematology, and infectious diseases.
Principal investigators · Prof. L. Antonioli, Prof. M. Fornai
Pharmacological strategies for gastrointestinal and immune-mediated diseases, focusing on purinergic signaling and intestinal barrier function.
Director · Prof. M. Fornai
Drug safety, pharmacovigilance, and pharmacoepidemiology research; part of the Tuscan Regional Pharmacovigilance Center (CRFV).
Two advanced training paths at the University of Pisa, from clinical research methodology to medical specialty practice.
Clinical trial methodology in oncology and specialty disciplines: study design, biostatistics, pharmacogenetics and AI applications in drug development. Career paths in pharma companies, CROs and hospitals.
Specialist training in predicting and evaluating responses to drugs and toxic substances in humans under normal and pathological conditions, combining theoretical, technical and clinical care competencies.
